rct AI Revenue and Competitors
Estimated Revenue & Valuation
- rct AI's estimated annual revenue is currently $6.8M per year.
- rct AI's estimated revenue per employee is $126,000
Employee Data
- rct AI has 54 Employees.
- rct AI grew their employee count by -28% last year.
rct AI's People
Name | Title | Email/Phone |
---|---|---|
1 | Co-founder & Chief Operating Officer | Reveal Email/Phone |
2 | Producer & Operation | Reveal Email/Phone |
rct AI Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $0.3M | 4 | N/A | N/A | N/A |
#2 | $3.4M | 30 | 7% | N/A | N/A |
#3 | $27M | 175 | 26% | N/A | N/A |
#4 | $7.7M | 61 | 0% | N/A | N/A |
#5 | $175.6M | 877 | -6% | $91.2M | N/A |
#6 | $1.5M | 18 | -5% | N/A | N/A |
#7 | $2M | 20 | N/A | N/A | N/A |
#8 | $0.2M | 3 | -70% | N/A | N/A |
#9 | $32M | 208 | 41% | N/A | N/A |
#10 | $1.3M | 16 | -33% | N/A | N/A |
What Is rct AI?
N/A
Total Funding
54
Number of Employees
$6.8M
Revenue (est)
-28%
Employee Growth %
N/A
Valuation
N/A
Accelerator
rct AI News
2022-04-20 - Unlearn Receives $50 Million to Accelerate Clinical Trials Using Artificial Intelligence
Artificial intelligence (AI) is being used in numerous industries to improve ... As in a traditional randomized controlled trial (RCT),...
2022-04-17 - Unlearn Closes $50 Million Series B Funding to Advance the Use of ...
As in a traditional randomized controlled trial (RCT), patients are ... For more information, please visit https://www.unlearn.ai or follow...
2022-03-22 - Delysium selects Polygon to build its AI-powered decentralized gaming experience
Delysium, an AI-powered, player-owned AAA web3 game, today announced an integration with Polygon ... Yuheng Chan, CEO of rct AI & Delysium.
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $10.2M | 54 | 10% | N/A |
#2 | $12.2M | 54 | 2% | N/A |
#3 | $8.7M | 54 | 6% | N/A |
#4 | $11.9M | 54 | 4% | N/A |
#5 | $15.8M | 54 | 4% | N/A |